NASDAQ · Biotechnology

NeOnc Technologies Holdings, Inc. (NTHI) Stock

$2.78 +9.88% NASDAQ: NTHI Healthcare

Valuation

MetricValue
Price$2.78
Market Cap$72.09M
P/E Ratio-1.22
P/B Ratio-3.61
P/S Ratio2750.00
EPS (TTM)$-3.23
52-Week High$12.99
52-Week Low$2.53
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE309.09%
ROA-902.18%
ROCE228.50%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity-0.02
Current Ratio0.05

Annual Financials (USD)

Metric2025
Revenue$0
Operating Profit$-58.0M
Net Profit$-62.0M
EPS$-3.23
Op Margin-145459.4%

Balance Sheet (USD)

Metric2025
Total Assets$3.0M
Total Liabilities$20.0M
Cash$0
Borrowings$6.0M

Latest News

NeOnc Receives FDA Written Feedback on NEO212 CMC Development and Capsule-to-Tablet Transition Stocktwits · Jul 15, 2026 NeOnc Technologies Receives UAE IND Approval for NEO100, Expanding Global Development Ahead of Anticipated Phase 2 Data Milestone Stocktwits · Jun 23, 2026 WSTPR Catalyst Watch: Abu Dhabi Regulatory Clearance Adds Momentum to NeOnc's Global Neuro-Oncology Strategy TMX Newsfile · Jun 22, 2026 NeOnc Technologies Secures UAE IND Approval for NEO212 Following Successful Phase 1 Completion, Advancing Toward Global Phase 2 Development Stocktwits · Jun 16, 2026 WSTPR Catalyst Watch: NeOnc Strengthens Capital Position Ahead of Potentially Transformational Neuro-Oncology Updates TMX Newsfile · Jun 15, 2026

Cash Flow (USD)

Metric2025
Operating Cash Flow$-20.0M
Investing Cash Flow$-1.0M
Financing Cash Flow$0
Net Cash Flow$0
Free Cash Flow$-21.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.05
EV / EBITDA-1.57
FCF Yield-30.11%
Quick Ratio0.14
Interest Coverage-12.41
Return 1Y-15.10%
Return 3Y—
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $336.64 -1.11% 38.93 $4.94T 0.32%
MSFTMicrosoft Corporation $535.07 +2.38% 28.68 $3.97T 0.76%
GOOGLAlphabet Inc. $351.66 +0.97% 16.94 $4.26T 0.26%
AMZNAmazon.com, Inc. $262.43 +3.29% 19.82 $2.82T 0.00%
METAMeta Platforms, Inc. $718.67 -0.31% 27.93 $1.83T 0.28%

About NeOnc Technologies Holdings, Inc.

NeOnc Technologies Holdings, Inc. is led by CEO Amir Farrokh Heshmatpour, employs 8 people, headquartered in US, publicly traded since 2025.

NeOnc Technologies Holdings, Inc. (NTHI) stock trades at $2.78 with a market capitalization of $72.09M. The stock is valued at a price-to-earnings (P/E) ratio of -1.22, price-to-book of -3.61, price-to-sales of 2750.00. Over the past 52 weeks the stock has ranged between $2.53 and $12.99, and currently trades 78.6% below its 52-week high.

On profitability, NeOnc Technologies Holdings, Inc. generates a return on equity (ROE) of 309.09% — well above the market average, a sign of a high-quality business, return on capital employed of 228.50%, an operating margin of 0.00%, a net profit margin of 0.00%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides